Evidence for the catalysis of Dextromethorphan O-demethylation by a CYP2D6-like enzyme in pig liver

This publication has 24 references indexed in Scilit:

• Differences in Caffeine 3-Demethylation Activity among Inbred Mouse Strains: A Comparison of HepaticCyp1a2Gene Expression between Two Inbred Strains
  Fundamental and Applied Toxicology, 1997
• Biotransformation of Chlorzoxazone by Heptatic Microsomes from Humans and Ten Other Mammalian Species
  Biopharmaceutics & Drug Disposition, 1997
• Early Clinical Experience with a Hybrid Bioartificial Liver
  Scandinavian Journal of Gastroenterology, 1995
• Treatment of Hepatic Failure with ex Vivo Pig-Liver Perfusion Followed by Liver Transplantation
  New England Journal of Medicine, 1994
• The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
  British Journal of Clinical Pharmacology, 1992
• Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]
  British Journal of Clinical Pharmacology, 1991
• Assessment of the mouse as an experimental model for studying polymorphic oxidation of the sparteine/debrisoquine type
  Biochemical Pharmacology, 1991
• Debrisoquine 4-Hydroxylase: Characterization of a New P450 Gene Subfamily, Regulation, Chromosomal Mapping, and Molecular Analysis of the DA Rat Polymorphism
  DNA, 1987
• Bufuralol 1'-hydroxylase activity of the rat
  Biochemical Pharmacology, 1986
• Stereo- and regioselectivity of hepatic oxidation in man ? Effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylation
  European Journal of Clinical Pharmacology, 1986